# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639991356428" (Language "en")

: finalstatus

: Package Leaflet type (#100000155538)

: 2015-02-07T13:28:17Zdate

: author See above (Organization/cfsb1639754108144)

: TEST PURPOSES ONLY - Monuril Vulcan ePItitle

: unrestrictedconfidentiality

# entry[].resource.section[].text.div
PACKAGE LEAFLET: INFORMATION FOR THE USER MONURIL 3 g granules for oral solution Fosfomycin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

# entry[].resource.section[].text.div
What in this leaflet

What Monuril is and what it is used for

What you need to know before you take Monuril

How to take Monuril

Possible side effects

How to store Monuril

Contents of the pack and other information

# entry[].resource.section[].title
1. What Monuril is and what it is used for

# entry[].resource.section[].text.div
1. What Monuril is and what it is used for Monuril contains the active substance fosfomycin (as fosfomycin trometamol). It is an antibiotic that works by killing bacteria which can cause infections. Monuril is used to treat uncomplicated infection of the bladder in women and female adolescents. Monuril is used as antibiotic prophylaxis for transrectal prostate biopsy in adult man.

# entry[].resource.section[].title
2. What you need to know before you take Monuril

# entry[].resource.section[].text.div
2. What you need to know before you take Monuril
Do not take Monuril if you:

are allergic to fosfomycin or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions Talk to your doctor, pharmacist or nurse before using Monuril if you suffer from one of the following disorders:

persistent infections of the bladder,

previously had diarrhea after taking any other antibiotics.

Conditions you need to look out for
Monuril can cause serious side effects. These include allergic reactions and an inflammation of the large intestine. You must look out for certain symptoms while you are taking this medicine, to reduce the risk of any problems. See “Serious side effects” in Section 4.
Children and adolescents
Do not give this medicine to children less than 12 years of age, as its safety and efficacy have not been established in this age group.
Other medicines and Monuril
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is especially important if you are taking:

or other medicinal products that increase the movement of food through the stomach and intestines, because they may reduce the uptake of fosfomycin by your body,metoclopramide

, as their ability to prevent your blood from clotting might be altered by fosfomycin and other antibiotics.anticoagulants

Monuril with food
Food may delay the absorption of fosfomycin. Therefore, this medicinal product should be taken on an empty stomach (2-3 hours before or 2-3 hours after a meal).
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are pregnant your doctor will only give you this medicine when it is clearly needed.

Breast-feeding mothers can take a single oral dose of this medicine.

Driving and using machines
You may experience side effects, such as dizziness, which may affect your ability to drive or use machines.
Monuril contains
Sodium This medicine contains less than 1 mmol sodium (23 mg) per sachet that is to say essentially 'sodium-free'. Sucrose If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. Sulphites May rarely cause severe hypersensitivity reactions and bronchospasm.

# entry[].resource.section[].text.div
3. How to take Monuril
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
In case of treatment of uncomplicated infection of the bladder, in women and female adolescents the recommended dose is 1 sachet of Monuril (3 g Fosfomycin).

When used as antibiotic prophylaxis for transrectal prostate biopsy the recommended dose is 1 sachet of Monuril (3 g fosfomycin) 3 hours prior to the procedure and 1 sachet of Monuril (3 g fosfomycin) 24 hours after the procedure.

Use in patients with renal impairment
This medicine should not be used in patients with severe renal impairment (creatinin clearance < 10 ml/min).
Use in children and adolescents
This medicine should not be used in children less than 12 years of age.
Method of administration
For oral use.
Take this medicine by mouth, on an empty stomach (2-3 hours before or 2-3 hours after a meal), preferably before going to bed after emptying the bladder.

Dissolve the content of one sachet in a glass of water and drink immediately.

If you take more Monuril than you should
If you accidentally take more than your prescribed dose, contact your doctor or pharmacist.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

# entry[].resource.section[].text.div
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects

While taking Monuril, if you develop any of the following symptoms you should stop taking the medicine and contact your doctor immediately:

anaphylactic shock, a life threatening type of allergic reaction (the frequency is unknown

swelling of the face, lips, tongue or throat with breathing difficulties (angioedema) (the frequency is unknown

moderate to severe diarrhea, abdominal cramps, bloody stools and/or fever may mean that you have an infection of the large intestine (antibiotic-associated colitis) (the frequency is unknown

Other side effects
Common (may affect up to 1 in 10 people):

headache

dizziness

diarrhea

nausea

indigestion

abdominal pain

infection of the female genital organs with symptoms like inflammation, irritation, itching (vulvovaginitis).

Uncommon (may affect up to 1 in 100 people):

vomiting

rash

urticaria

itching

Not known (frequency cannot be estimated from the available data):

allergic reactions.

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

# entry[].resource.section[].text.div
Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the blister after “EXP”. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

# entry[].resource.section[].title
6. Contents of the pack and other information

# entry[].resource.section[].text.div
6. Contents of the pack and other information

What Monuril contains

The active substance is fosfomycin. Each sachet contains 5.631 g of fosfomycin trometamol, equivalent to 3 g of fosfomycin

the other ingredients are mandarin flavour, orange flavour, saccharin, sucrose (see section 2 for information on sucrose).

What Monuril looks like and contents of the pack
White granules for oral solution in a single dose sachet.
Sachets are four layers laminate of: paper/polyethylene/aluminium/polyethylene.

Monuril is available in packs containing:
1 sachet of 8 g of granules (3 g fosfomycin) 2 sachets of 8 g of granules (3 g fosfomycin) 5 sachets of 8 g of granules (3 g fosfomycin). Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder: Zambon S.p.A. Via Lillo del Duca, 10 20091 Bresso (Milan) - Italy Tel: +39 02 665 241 Fax: +39 02 665 01 492
Manufacturer:
Zambon S.p.A. Via della Chimica, 9 36100 Vicenza - Italy
Distributor
Profile Pharma Limited Bicentennial Building Southern Gate West Sussex PO19 8EZ UK Tel: +44 (0) 800 0288 942 Email: info.profilepharma@zambongroup.com
This leaflet was last revised in November 2020.

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639753766266"

: id: ORG-100000380 (OFFICIAL)identifier

: trueactive

: Manufacturer type (#220000000033)

: Zambon S.p.A.name

: Via della Chimica, 9 36100 Vicenza – Italy(WORK)address

# entry[].resource.contact[].address.text
Via della Chimica, 9 36100 Vicenza – Italy

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639754108144"

: id: ORG-100000380 (OFFICIAL)identifier

: trueactive

: Marketing authorisation holder type (#220000000034)

: Zambon S.p.A.name

: telecom+39 02 665 241

: Via Lillo del Duca, 10 20091 Bresso (Milan) – Italy(WORK)address

# entry[].resource.contact[].address.text
Via Lillo del Duca, 10 20091 Bresso (Milan) – Italy

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639015880655"

: id: ORG-100013412 (OFFICIAL)identifier

: trueactive

: Medicines Regulatory Authority type (#/#220000000033)

: European Medicines Agencyname

: Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)address

# entry[].resource.contact[].address.text
Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands

# entry[].resource.contact[].address.line[]
Carretera De Martorell 41 61, Poligono Industrial Nord-Est

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639761980721"

: id: PL 31654/0006 (OFFICIAL)identifier

: subject See above (MedicinalProductDefinition/cfsb1639760186202)

: Marketing Authorisation type (#/#100000072062)

: European Union region (unknown#eu)

: Active status (PublicationStatus

: 2015-02-07T13:28:17ZstatusDate

: holder See above (Organization/cfsb1639754108144)

: regulator See above (Organization/cfsb1639015880655)

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639760186202"

: id: PL 31654/0006 (OFFICIAL)identifier

: Marketing Authorisation type (#/#100000072062)

: Human use domain (#/#100000000012)

: Active status (PublicationStatus

: Medicinal product subject to medical prescription legalStatusOfSupply (#/#100000072084)

name

: MONURIL 3 g granules for oral solutionproductName

: Full name type (#/#220000000001)

NameParts

- | Part | Type
* | granules for oral solution | Pharmaceutical dose form part (#/#220000000005)

CountryLanguages

- | Country | Jurisdiction | Language
* | gb (unknown#gb) | European Union (unknown#eu) | English (Tags for the Identification of Languages

# entry[].resource.legalStatusOfSupply.text
Medicinal product subject to medical prescription

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639758328687"

: id: PL 31654/0006-5 (OFFICIAL)identifier

: 5 sachets of 8 g of granules (3 g fosfomycin).name

: Chemical Medicinal Product type (#100000155527)

: packageFor See above (MedicinalProductDefinition/cfsb1639760186202)

: Active status (PublicationStatus

: 2008-09-19statusDate

: 5 SachetcontainedItemQuantity (Details: [not stated] code 200000002143 = '200000002143')

: manufacturer See above (Organization/cfsb1639753766266)

package

: Sachet type (#200000002143)

: Paper material (#200000003207) (#200000003214) (#200000003200)

: manufacturer See above (Organization/cfsb1639753766266)

containedItem

# entry[].resource.name
5 sachets of 8 g of granules (3 g fosfomycin).

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639764389611"

: id: PL 31654/0006-2 (OFFICIAL)identifier

: 2 sachets of 8 g of granules (3 g fosfomycin).name

: Chemical Medicinal Product type (#100000155527)

: packageFor See above (MedicinalProductDefinition/cfsb1639760186202)

: Active status (PublicationStatus

: 2 SachetcontainedItemQuantity (Details: [not stated] code 200000002143 = '200000002143')

: manufacturer See above (Organization/cfsb1639753766266)

package

: Sachet type (#200000002143)

: Paper material (#200000003207) (#200000003214) (#200000003200)

: manufacturer See above (Organization/cfsb1639753766266)

containedItem

# entry[].resource.name
2 sachets of 8 g of granules (3 g fosfomycin).

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639764389612"

: id: PL 31654/0006-1 (OFFICIAL)identifier

: 1 sachet of 8 g of granules (3 g fosfomycin).name

: Chemical Medicinal Product type (#100000155527)

: packageFor See above (MedicinalProductDefinition/cfsb1639760186202)

: Active status (PublicationStatus

: 1 SachetcontainedItemQuantity (Details: [not stated] code 200000002143 = '200000002143')

: manufacturer See above (Organization/cfsb1639753766266)

package

: Sachet type (#200000002143)

: Paper material (#200000003207) (#200000003214) (#200000003200)

: manufacturer See above (Organization/cfsb1639753766266)

containedItem

# entry[].resource.name
1 sachet of 8 g of granules (3 g fosfomycin).

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639760977050"

: id: 0xE857DA811B4A6F3BD57810C45D2EA1ED (OFFICIAL)identifier

: activestatus

: formOf See above (MedicinalProductDefinition/cfsb1639760186202)

: Granules and solvent for oral suspension administrableDoseForm (#/#100000116155)

: producedFrom See above (ManufacturedItemDefinition/cfsb1639756818482)

routeOfAdministration

: oral use code (#100000073619)

TargetSpecies

- | Code
* | Human (#/#100000109093)

# entry[].resource.administrableDoseForm.coding[].display
Granules and solvent for oral suspension

# entry[].resource.administrableDoseForm.text
Granules and solvent for oral suspension

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639756818482"

: id: PL 31654/0006 (OFFICIAL)identifier

: activestatus

: Granules for oral solution manufacturedDoseForm (#100000073365)

: Sachet unitOfPresentation (#200000002143)

: manufacturer See above (Organization/cfsb1639753766266)

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639762372322"

: activestatus

: Excipient role (#100000072082)

Manufacturers

- | Manufacturer
* | See above (Organization/cfsb1639753766266)

substance

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639754408039"

: activestatus

: active role (#/#00000072072)

Manufacturers

- | Manufacturer
* | See above (Organization/cfsb1639753766266)

substance

strength

: 5.631 gpresentation

: active ingredient - moiety is basis of strength basis (RoleClass

referenceStrength

: 3 gstrength

# entry[].resource.substance.strength[].basis.coding[].display
active ingredient - moiety is basis of strength

# entry[].resource.substance.strength[].basis.text
active ingredient - moiety is basis of strength

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639762593730"

: activestatus

: Excipient role (#100000072082)

Manufacturers

- | Manufacturer
* | See above (Organization/cfsb1639753766266)

substance

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639762372321"

: activestatus

: Excipient role (#100000072082)

Manufacturers

- | Manufacturer
* | See above (Organization/cfsb1639753766266)

substance

# entry[].resource.text.div
Generated Narrative

Resource "cfsb1639762372323"

: activestatus

: Excipient role (#100000072082)

Manufacturers

- | Manufacturer
* | See above (Organization/cfsb1639753766266)

substance